Benjamin P. Saylor

Benjamin P. Saylor is associate editor of Urology Times, an Advanstar Communications publication.


Molecular signatures linked to long-term apalutamide benefit in nonmetastatic CRPC

February 13, 2021

“Among patients treated with apalutamide, molecular signatures indicative of increased immune activity, decreased vascularization, or decreased proliferative capacity at baseline were each independently associated with long-term response,” reported Felix Y. Feng, MD.